E2F8 and cancer: The opposing functions of DBP and E2F8 as enhancer and repressor respectively, in Th9 cells contribute to Th9-medaited anti-tumor effects in experimental models of melanoma and fibrosarcoma and suggest their biological significance in cancer immunotherapy.